Schedule 13G ownership disclosure

Olema Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 68062P106

Event date: 2025-03-31

Filing-level shares
6,843,954
Percent of class
9.99%
  • Bain Capital Life Sciences Opportunities IV, L.P.

    Shares: 6,843,954 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-071958
Form type
SCHEDULE 13G/A
Filer
Bain Capital Life Sciences Opportunities IV, L.P.
CIK
CIK 2015553
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub